IDEAYA Biosciences, Inc. IDYA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$98.54M-18.3% | -$83.27M-170% | $119.24M+254% | -$77.49M-7.4% | -$72.18M+44.6% | ||
| $688K-4.6% | $721K+9.1% | $661K-7.9% | $718K+19.7% | $600K+4.9% | ||
| $14.54M+23.3% | $11.79M-3.5% | $12.22M+2.9% | $11.87M+15.9% | $10.24M+7.9% | ||
| —— | -$0— | -$0— | -$0— | -$0+100% | ||
| $3.05M— | —— | $1.19M— | —— | $2.73M-8.3% | ||
| $2.73M— | —— | $7.51M+55.0% | $4.84M+68.5% | $2.88M+26.4% | ||
| -$3.03M-154% | $5.56M— | $0-100% | $500K-74.6% | $1.97M+14.6% | ||
| -$587K— | —— | —— | —— | $0— | ||
| $455K-4.4% | $476K+29.0% | $369K-28.3% | $515K-3.4% | $533K+651% | ||
| -$75.17M+16.9% | -$90.5M-164% | $142.21M+328% | -$62.47M-3.5% | -$60.34M+50.4% | ||
| $967K+190% | $333K+693% | $42K-93.7% | $663K-50.2% | $1.33M+20.7% | ||
| $42.61M-82.0% | $236.14M+69.9% | $138.99M+9.0% | $127.55M+21.2% | $105.21M-68.8% | ||
| $162.53M+17.0% | $138.95M-23.1% | $180.8M+3.8% | $174.13M-6.6% | $186.35M+32.1% | ||
| $118.95M— | —— | $41.77M-9.0% | $45.92M-42.5% | $79.82M+140% | ||
| $1.19M+162% | -$1.93M-602% | $384K-6.3% | $410K-63.8% | $1.13M— | ||
| $1.18M-44.6% | $2.13M+608% | $301K-75.0% | $1.21M-95.4% | $26.14M+850% | ||
| $44.96M— | —— | $184.28M— | —— | $45.62M+114% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $1.21M-20.5% | $1.52M-23.1% | $1.98M-26.4% | $2.69M-28.7% | $3.78M-23.1% | ||
| $2.73M— | —— | $7.51M+55.0% | $4.84M+68.5% | $2.88M+26.4% | ||
| —— | $1.49M0.0% | $1.49M0.0% | $1.49M0.0% | $1.49M— | ||
| $686K+2.5% | $669K+3.2% | $648K+3.0% | $629K+2.9% | $611K+810% | ||
| -$3.03M-154% | $5.56M— | $0-100% | $500K-74.6% | $1.97M+14.6% | ||
| $455K-4.4% | $476K+29.0% | $369K-28.3% | $515K-3.4% | $533K+651% | ||
| $162.53M+17.0% | $138.95M-23.1% | $180.8M+3.8% | $174.13M-6.6% | $186.35M+32.1% | ||
| -$9K— | —— | —— | —— | $25.01M— | ||
| $1.2M+177% | $433K— | $0-100% | $3K-99.5% | $654K+225% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $0— | —— | —— | —— | $6.19M+1,242% | ||
| $98K— | —— | —— | —— | $0— | ||
| -$76.14M+16.2% | -$90.83M-164% | $142.17M+325% | -$63.14M-2.4% | -$61.67M+49.8% | ||
| -$76.14M+16.2% | -$90.83M-164% | $142.17M+325% | -$63.14M-2.4% | -$61.67M+49.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does IDEAYA Biosciences, Inc. generate?
- IDEAYA Biosciences, Inc. (IDYA) generated -$85.9M in operating cash flow over the trailing twelve months.
- What is IDEAYA Biosciences, Inc.'s free cash flow?
- After $2.0M of capital expenditures, IDEAYA Biosciences, Inc.'s free cash flow was -$87.9M over the trailing twelve months, up 67.2% year over year.
- Where does IDEAYA Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
